Zynex Profit Margin 2006-2020 | ZYXI

Current and historical gross margin, operating margin and net profit margin for Zynex (ZYXI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Zynex net profit margin as of March 31, 2020 is 19.57%.
Zynex Annual Profit Margins
Zynex Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.853B $0.045B
Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $165.688B 28.73
Medtronic (MDT) Ireland $120.891B 19.64
Stryker (SYK) United States $66.633B 21.63
Boston Scientific (BSX) United States $48.278B 22.70
Baxter (BAX) United States $43.462B 26.53
Lonza Group Ag (LZAGY) Switzerland $42.008B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $28.981B 0.00
Terumo (TRUMY) Japan $28.231B 36.09
ResMed (RMD) United States $28.021B 44.22
Zimmer Biomet Holdings (ZBH) United States $24.281B 15.28
Sunny Optical Technology (SNPTF) China $20.840B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.828B 0.00
Bio-Rad Laboratories (BIO) United States $14.172B 64.51
Insulet (PODD) United States $13.329B 1320.56
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $10.288B 80.85
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
GN STORE NORD (GNNDY) Denmark $7.676B 39.13
Perrigo (PRGO) Ireland $7.396B 13.23
Hill-Rom Holdings (HRC) United States $7.394B 20.84
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.620B 0.00
Haemonetics (HAE) United States $4.381B 26.31
Neogen (NEOG) United States $4.079B 69.10
GW Pharmaceuticals (GWPH) United Kingdom $3.977B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.923B 0.00
ICU Medical (ICUI) United States $3.761B 27.44
Agios Pharmaceuticals (AGIO) United States $3.676B 0.00
Envista Holdings (NVST) United States $3.138B 0.00
NuVasive (NUVA) United States $2.743B 22.03
TG Therapeutics (TGTX) United States $2.661B 0.00
National Vision Holdings (EYE) United States $2.237B 38.71
AtriCure (ATRC) United States $1.768B 0.00
MacroGenics (MGNX) United States $1.508B 0.00
NanoString Technologies (NSTG) United States $1.361B 0.00
Aurora Cannabis (ACB) Canada $1.333B 0.00
Aphria (APHA) Canada $1.206B 0.00
Cerus (CERS) United States $1.148B 0.00
Meridian Bioscience (VIVO) United States $1.069B 40.24
Cardiovascular Systems (CSII) United States $1.042B 0.00
Vapotherm (VAPO) United States $1.014B 0.00
Phibro Animal Health (PAHC) United States $0.996B 19.85
PetIQ (PETQ) United States $0.961B 27.75
DFB Healthcare Acquisitions (AHCO) United States $0.890B 148.08
OraSure Technologies (OSUR) United States $0.860B 173.13
InMode (INMD) Israel $0.853B 18.02
Quanterix (QTRX) United States $0.779B 0.00
Omeros (OMER) United States $0.731B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.646B 46.29
BioLife Solutions (BLFS) United States $0.572B 162.82
VAREX IMAGING (VREX) United States $0.571B 14.18
Lantheus Holdings (LNTH) United States $0.571B 11.49
Surmodics (SRDX) United States $0.562B 67.75
LeMaitre Vascular (LMAT) United States $0.521B 29.67
Owens & Minor (OMI) United States $0.466B 12.33
Viemed Healthcare (VMD) United States $0.413B 36.62
Cytosorbents (CTSO) United States $0.368B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.343B 0.00
HEXO (HEXO) $0.328B 0.00
Utah Medical Products (UTMD) United States $0.302B 21.90
Organigram Holdings (OGI) Canada $0.262B 0.00
InfuSystems Holdings (INFU) United States $0.224B 124.11
Female Health (VERU) United States $0.209B 0.00
Chimerix (CMRX) United States $0.192B 0.00
Surface Oncology (SURF) United States $0.161B 0.00
Bovie Medical (APYX) United States $0.158B 0.00
Fonar (FONR) United States $0.134B 11.83
Exagen (XGN) United States $0.133B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
United Health Products (UEEC) United States $0.117B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.114B 0.00
Liberty Health Sciences (LHSIF) Canada $0.108B 0.00
Wound Management Technologies (SMTI) United States $0.104B 0.00
Evolus (EOLS) United States $0.102B 0.00
MTech Acquisition (KERN) United States $0.096B 0.00
Chembio Diagnostics (CEMI) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.080B 0.00
Nephros (NEPH) United States $0.068B 0.00
United-Guardian (UG) United States $0.066B 15.32
Capricor Therapeutics (CAPR) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 0.00
Brainsway (BWAY) Israel $0.060B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00